| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |